Cancer Immunotherapy Induced Rheumatic Disease

Laura Cappelli organized an open discussion at #ACR19 among oncologists and rheumatologists to address the rheumatic problems seen in some patients on cancer-fighting checkpoint inhibitors.

Cappelli says oncologists and rheumatologists should take a team approach to treating patients with cancer who are on checkpoint inhibitors and are experiencing painful rheumatic conditions such as inflammatory arthritis. 

Created by

Johns Hopkins Medicine

Related Presenters

Laura Capelli, MD, MHS, MS

Laura Capelli, MD, MHS, MS

Assistant Professor of Medicine

View full profile